The DOI matches its Crossref record; 272 of the 273 references it cites were found in a registry or an index.
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
Open accessAbstract
Since its identification in 2000, the interest of scientists in the hepatokine fibroblast growth factor (FGF) 21 has tremendously grown, and still remains high, due to a wealth of very robust data documenting this factor's favorable effects on glucose and lipid metabolism in mice.For more than ten years now, intense in vivo and ex vivo experimentation addressed the physiological functions of FGF21 in humans as well as its pathophysiological role and pharmacological effects in human metabolic disease.This work produced a comprehensive collection of data revealing overlaps in FGF21 expression and function but also significant differences between mice and humans that have to be considered before translation from bench to bedside can be successful.This review summarizes what is known about FGF21 in mice and humans with a special focus on this factor's role in glucose and lipid metabolism and in metabolic diseases, such as obesity and type 2 diabetes mellitus.We highlight the discrepancies between mice and humans and try to decipher their underlying reasons.(Endocrine Reviews 38: 468 -488, 2017) W ith a prevalence of ~% in adults, type diabetes mellitus (TD) is the most prominent metabolic disease worldwide (World Health Organization fact sheet on diabetes at http://www.who. int/mediacentre/factsheets/fs/en).The hallmark of the disease, that is, hyperglycemia, results from insulin resistance of liver, skeletal muscle, adipose tissue, and brain and a concomitant failure of pancreatic b-cells to compensate for this resistance by increased insulin secretion ().Current therapeutic options aim at reducing insulin resistance (metformin, thiazolidinediones), enhancing insulin secretion (sulfonylureas, meglitinides, dipeptidyl peptidase IV inhibitors, incretin mimetics), or excreting glucose via the urine (sodium/glucose cotransporter inhibitors), but a progressive loss of b-cell function and mass is often observed ().Eventually, the ultima ratio to normalize blood glucose is the replacement of endogenous insulin by injection of human recombinant insulin or insulin analogs.New insights into the molecular pathomechanisms behind insulin resistance and b-cell failure point toward a crucial role for a well-balanced humoral crosstalk between metabolically relevant tissues (e.g., adipose, muscle, liver).Highly relevant players and promising targets for novel therapeutic strategies in this crosstalk were recently identified, among them fibroblast growth factor (FGF) (-).FGF is an endocrine factor secreted by liver acting as a metabolic regulator.Interest in the metabolic effects of FGF was aroused by the emergence of FGF as hit in an in vitro assay testing secreted proteins of unknown function for stimulation of glucose uptake in murine T-L adipocytes in an insulin-independent manner ().Based mainly on preclinical studies in mice showing improvements in glucose and lipid metabolism, FGF emerged as an interesting new candidate for TD treatment,
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FGF21 mainly binds to FGFR1 (FGFR1b and FGFR1c) and to a lower extent to FGFR4.33”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Li, Y., Choi, J. H., Giang, A.-H., Khandekar, M. J., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,406
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Receptor Specificity of the Fibroblast Growth Factor Family
Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601252200 · Cited by 1,164
Flagged first, then by citations
1 of the 273 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–268 of 268
Pedersen, A. K. N., Hage, C., Jessen, N., Mellbin, L., & Bjerre, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111738 · Cited by 4
El‐Magd, N. F. A., Ramadan, N. M., Hassan, Y. F., Mahmoud, A. M., Azzam, M. M., & Eraky, S. M. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110237 · Cited by 3
Ebrahimi, F., Urwyler, S. A., Betz, M. J., Christ, E., Schüetz, P., Müeller, B., Donath, M. Y., & Christ‐Crain, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-87207-w · Cited by 3
Weight regain after bariatric surgery: Promoters and potential predictors
Demerdash, H. M. (2021) · World Journal of Meta-Analysis · doi:10.13105/wjma.v9.i5.438 · Cited by 3
Shestopalov, A. V., Ganenko, L. A., Григорьева, Т. В., Лайков, А. В., Васильев, И. Ю., Колесникова, И. М., Набока, Ю. Л., Волкова, Н. И., & Rumyantsev, S. A. (2023) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2023.004 · Cited by 3
Yong, F., Yan, M., Zhang, L., Ji, W., Zhao, S., & Gao, Y. (2023) · Veterinary Sciences · doi:10.3390/vetsci10070452 · Cited by 3
FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
Klímová, J., Zelinka, T., Rosa, J., Štrauch, B., Haluzíková, D., Haluzı́k, M., Holaj, R., Krátká, Z., Kvasnička, J., Ďurovcová, V., et al. (2019) · Cancers · doi:10.3390/cancers11040485 · Cited by 3
Nutritional Intake and the Risk for Non-alcoholic Fatty Liver Disease (NAFLD)
Bergheim, I., & Schattenberg, J. M. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-599-1 · Cited by 4
Pancreatic Islets as a Target of Adipokines
Reiterer, M., Gilani, A., & Lo, J. C. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210044 · Cited by 3
Ishii, H., Kitaura, S., Wada, T., & Shimba, S. (2025) · npj Biological Timing and Sleep · doi:10.1038/s44323-025-00023-7 · Cited by 2
How Exercise Affects Exerkines in Metabolic Syndrome
Babaei, P., & Yadegari, F. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2720-5398 · Cited by 2
Host Response Diagnostics in Pneumonia.
Pickens, C. I., & Cruz, C. D. (2026) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.12.009 · Cited by 2
Wu, C.-C., Hung, C.-J., Wang, Y., Lin, S., Chen, W., Kuan, Y., Liao, S., Yang, C., & Chen, C. (2020) · Molecules · doi:10.3390/molecules25143229 · Cited by 2
Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Matikainen, N., & Söderlund, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00013-6 · Cited by 2
Jain, U., Srivastava, P., Sharma, A., Sinha, S., & Johari, S. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998265915231116043813 · Cited by 3
Han, S., Chen, Q., Zhu, Q., & Han, W. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.108163 · Cited by 2
Vincenzo, A. D., Granzotto, M., Crescenzi, M., Fioretto, P., Vettor, R., & Rossato, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01879-3 · Cited by 2
Chiu, L.-T., Hung, C.-D., Lin, L., Lin, Y., & Hsu, B. (2022) · International Journal of Hypertension · doi:10.1155/2022/7098458 · Cited by 2
Lower melanoma pulmonary metastatic burden in obese mice: role of FGF-21
Fonseca, M., Soares, R., & Coelho, P. (2021) · Melanoma Research · doi:10.1097/cmr.0000000000000781 · Cited by 2
Bicistronic reporter mice for monitoring of Fgf21 expression
Pham, H. T. A., Lee, S., & Lee, Y. J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.045 · Cited by 2
Agarwal, S., Sharma, S., Grover, I., Singh, N., Ahmed, S., & Saraya, A. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01504-y · Cited by 2
Li, X., Shen, H., Zhou, T., Cao, X., Chen, Y., Liang, Y., Lu, T., He, J., Dou, Z., Liu, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-349444/v1 · Cited by 2
White, M. F. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch9 · Cited by 2
Effect of type 2 diabetes on the inducible degrader of LDL receptor
Lam, S., Lui, D. T. W., Shiu, S. W. M., Wong, Y., & Tan, K. C. B. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100380 · Cited by 1
Glucagon and the metabolic syndrome
Welch, A., & Vella, A. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00011-6 · Cited by 1
Molecular Mechanisms of Cell Protection Against Injury—The Foundation of Cell Protective Engineering
Liu, S. Q. (2025) · ASME Open Journal of Engineering · doi:10.1115/1.4067563 · Cited by 1
Elhusseiny, R., Ihsan, M., Labidi, M., Alhammoud, M., Mtibaa, K., Nader, N., Nasir, N., Farooq, A., Papakostas, E., Olory, B. C. R., et al. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003825 · Cited by 1
GH replacement therapy in adults stimulates fibroblast activation protein-α activity
Bæk, A., Pedersen, A. K. N., Billeskov, T. B., Dollerup, O. L., Arlien-Søborg, M. C., Jessen, N., Bjerre, M., & Jørgensen, J. O. L. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf244 · Cited by 1
Betulin Activates Hepatic PPARα-FGF21 Signaling to Combat Obesity
Ma, L., Huang, T., Luo, X., Jin, X., Jiang, X., Jin, C., Feng, B., Che, L., Xu, S., Lin, Y., et al. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c09970 · Cited by 1
Bayat, T., Popy, F. Y., Gee, R. R. F., Barr, B., Olayiwola, Y., Gutierrez, J. S. S., Štepihar, D., Díaz-Riaño, J., Myers, S., Cokan, K. B., et al. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020139 · Cited by 1
Wali, J. A., Ramos-Nieves, J. M., Binia, A., & van der Beek, E. M. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100713 · Cited by 1
Zhang, X., Zhao, Y., Liang, X., Zhang, L., Li, K., Sun, Z., & Zhao, Y. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13775 · Cited by 1
Pancreatic Islets as a Target of Adipokines
Reiterer, M., Gilani, A., & Lo, J. C. (2022) · Comprehensive physiology · doi:10.1002/j.2040-4603.2022.tb00238.x · Cited by 1
Millward, D. J. (2025) · Proceedings of The Nutrition Society · doi:10.1017/s0029665125100591 · Cited by 2
Wäse, K., Bartels, T., Schwahn, U., & Kabiri, M. (2023) · Toxicologic Pathology · doi:10.1177/01926233231164097 · Cited by 1
Gehring, J. (2020) · Archives of Diabetes & Obesity · doi:10.32474/ado.2020.03.000154
Alliouachene, S., Kieswich, J. E., Bilanges, B., McCafferty, K., Thiemermann, C., Vanhaesebroeck, B., & Yaqoob, M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16470
Are diabetes and depression related? Fibroblast growth factors in depression
Schoeman, R. (2021) · South African General Practitioner · doi:10.36303/sagp.2021.2.2.0054
Juszczyńska, K. (2021) · Farmacja Polska · doi:10.32383/farmpol/138770
Identification of potent novel biomarkers related to Osteoporosis through bioinformatics approachPreprint
., K., Bhushan, R., Kusum, K., Dubey, P. K., & More, R. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1311533/v1
Predictive Effect of Novel Markers on Cardiovascular Disease
邹, 京. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.124417
Rodríguez‐Ayllón, M., Plaza‐Florido, A., Méndez-Gutiérrez, A., Altmäe, S., Solis‐Urra, P., Aguilera, C. M., Catena, A., Ortega, F. B., & Esteban‐Cornejo, I. (2022) · medRxiv · doi:10.1101/2022.07.28.22278146
Halawa, M. R., Kolaib, M. H., Shaheen, O. M. M., Marawan, D. A., & Elhalawany, S. H. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.258439
Çetiner, S. (2023) · Eurasian Journal of Medical Investigation · doi:10.14744/ejmi.2023.59132
Abudigin, W. I., Bajaber, A. S., & Subash‐Babu, P. (2024) · Research Square · doi:10.21203/rs.3.rs-3917098/v1
Lan, J., Guo, H., Zou, J., Xue, J., Ni, H., Wang, L., Ren, T., Chai, S., Jiang, H., Gou, C., et al. (2024) · Portal hypertension & cirrhosis · doi:10.1002/poh2.89
Role of Myokines and prospects for their role in Diabetes Mellitus Therapy
Nuriya, K., Farida, M., Sharma, R., Liliya, S., Mkhitaryan, X. E., Chergizova, B., Salikhova, Y., Niyazova, Y., Ryspayeva, G., Evnevich, A., et al. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00786
Non-alcoholic fatty liver disease and osteoporosis: a bi-directional association
Dudinskaya, Е. N., & Onuchina, Y. S. (2024) · Problems of Geroscience · doi:10.37586/2949-4745-4-2024-171-180
Alenazi, M. A., Sabico, S., Alnaami, A. M., Wani, K., Hussain, S. D., & Al‐Daghri, N. M. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05833-z
FGF21 is a novel biomarker to predict fragility fractures in patients with type 2 diabetes mellitus
Phimphilai, M., Phrommintikul, A., Wongcharoen, W., Hengjeerajarus, N., Karndumri, K., Chattipakorn, N., & Chattipakorn, S. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-15104-7
The value of fibroblast growth factor 21 in health and pathology
Akhverdyan, Y., Papichev, E., Zavodovsky, B. V., Polyakova, Y. V., Seewordova, L. E., & Сергеевна, Р. Е. (2025) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2025-40-3-28-35
Main Types of Fibroblast Growth Factors: Biological Functions and Significance
Zagrebin, V. L., Derevyanko, I. V., SIM, G. A., & Plachinta, S. G. (2025) · Journal of Anatomy and Histopathology · doi:10.18499/2225-7357-2025-14-3-77-83
Myokine-Mediated Muscle-Kidney Crosstalk
Formenti, P., & Umbrello, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-01024-7_14
Hepatocyte Piezo1 regulates glycogen metabolism via the FGF21-STAT3 pathway
Tao, T., Yang, K., Li, Z., Zhang, M., Zhang, Z., Guo, J., Chen, H., & Xu, G. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05921-4
Li, X., Shen, H., Zhou, T., Cao, X., Chen, Y., Liang, Y., Lu, T., He, J., Dou, Z., Liu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821057
Li, X., Shen, H., Zhou, T., Cao, X., Chen, Y., Liang, Y., Lu, T., He, J., Dou, Z., Liu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821060
Zulfiqar, Z., Asif, M. A., Sun, J., Wang, H., Jiawen, C., Zhu, X., Wang, Z., Sun, H., Cui, Y., Liu, B., et al. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106440
Jiang, B., Chen, B., Yang, Y., Chen, Y. N., & Liu, W. (2026) · Biology · doi:10.3390/biology15060461
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
Ghanem, M. (2023) · theses.fr (ABES) · doi:10.70675/fd0d64f8zacf4z4856z9b1az66d4df37a332
Roisné-Hamelin, G. (2024) · theses.fr (ABES) · doi:10.70675/006069a1zb2b5z45e8zbe4fz5af5e3b6e229
Liu, Z., Chen, B., Han, W., Cheng, L., Li, X., Zhang, Y., Wang, D., Li, Y., Wang, Y., wang, X., et al. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.115991
Ageing liver in the era of MASLD: risks, mechanisms and treatment opportunities
Alqahtani, S. A., Schneider, C. V., & Schattenberg, J. M. (2026) · Frontline Gastroenterology · doi:10.1136/flgastro-2026-103677
Li, Q., Ma, X., Yuan, K., Li, J., Fu, L., Liu, N., Hu, J., Chen, X., Zhang, Y., Chen, X., et al. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag054
Li, C., Tang, C., Lin, B., Song, X., Zhang, X., Liu, P., Xu, C., & Yu, C. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.08.006
Li, Z., Lin, C., Tang, L., Xu, Y., Liang, J., Pan, D., Huang, Z., Xie, X., Wang, Y., Qin, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177527
Metadata
- Authors
- Staiger, H., Keuper, M., Berti, L., Hrabě de Angelis, M., & Häring, H.-U.
- Affiliations
- Helmholtz Munich (DE)
- Institute of Experimental Genetics, Helmholtz Center Munich, German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Corresponding author
- Staiger, Harald
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2017-07-28
- Volume
- 38
- Issue
- 5
- Pages
- 468-488
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2741980484
- Cited by
- 270
- References
- 273
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 27 · 2022: 36 · 2021: 64 · 2020: 33 · 2019: 33 · 2018: 16 · 2017: 1
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Eberhard Karls Universität Tübingen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- FGF21, hepatokines, glucose metabolism, lipid metabolism, type 2 diabetes, obesity, insulin resistance, beta-cell dysfunction, metabolic disorders, translational research, therapeutic target, adipose tissue, liver, skeletal muscle, gut microbiota, gut-liver axis, gut-brain axis
- MeSH terms
- Adipose Tissue, Animals, Bone and Bones, Brain, Diabetes Mellitus, Type 2, Fatty Liver, Fibroblast Growth Factors, Glucose, Humans, Metabolic Diseases, Nutritional Physiological Phenomena, Obesity, Signal Transduction, Exercise, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
